Best Target therapy for lung cancer doctors: TOP 25 doctors

Specializes in medical oncology and chemotherapy at Anadolu Medical Center – excels in targeted therapies for lung cancer.

• Completed medical oncology training at Marmara University
• Placed 3rd in Turkey's medical oncology specialty exam
• Led international clinical studies in medical oncology
• Former head of medical oncology at Haydarpaşa Numune Hospital

Dr. Solak specializes in lung cancer treatment with fellowship training at Hacettepe University Cancer Institute, one of Turkey's leading oncology centers.

• Trained at The University of Texas MD Anderson Cancer Center
• Experience with targeted therapies for various cancers including lung cancer
• Specializes in breast, ovarian, and gastrointestinal cancers as well
• Graduated from Hacettepe University – Turkey's top medical school

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with over 41 years of experience specializing in lung cancer and sarcoma treatments.

• Fellowship-trained in sarcoma at Institut Gustave Roussy in Paris
• ESMO Faculty member for soft tissue and bone sarcoma
• Vice Chairman of Sourasky's Ethical Committee
• Published research on tumor immunology and targeted therapies

Dr. Ari Raphael leads groundbreaking research in lung cancer at Tel Aviv Sourasky Medical Center, focusing on genomic profiling and immunotherapy.

• Principal investigator for multiple clinical trials on NSCLC treatments
• Expert in liquid biopsies and comprehensive genomic profiling
• Member of IASLC and ESMO, key organizations in lung cancer research
• Moderator of the Israeli Lung Cancer Society's Molecular Tumor Board
• Recipient of ISCORT research grant and teaching awards

Dr. Vergés specializes in ophthalmology with a focus on cataract and neurophysiological mechanisms of vision, backed by decades of research and clinical practice.

• Holds a PhD in Biology from Harvard University
• Director of the Ophthalmology Service at Dexéus University Hospital
• Recipient of the National Research Prize for his work on tear secretion
• Member of the International Society of Refractive Surgery and American Academy of Ophthalmology

Phd Viola Fox leads a certified cancer center specializing in targeted therapies – combining clinical expertise with molecular biology research.

• Specialized in hematology, oncology, and immunology
• Chief Physician at BKZ Solingen's cancer center
• Active researcher in molecular cancer mechanisms
• Qualified specialist in genetics
• Member of American Association for Cancer Research

Specializes in target therapy for lung cancer – Dr. Alemdar combines academic rigor with extensive clinical experience at Medical Park Antalya Hospital Complex.

• Trained in medical oncology at Akdeniz University Faculty of Medicine
• 20 years of experience in internal medicine and oncology
• Works with interdisciplinary teams for comprehensive lung cancer treatment

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in targeted cancer therapies, with over 22 years of experience of experience in personalized medicine.

• Specializes in breast cancer and gynecologic malignancies
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Published extensively on biomarker development and tumor biology
• Active in European oncology networks

Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings targeted expertise to complex oncology cases at Istinye Liv University Hospital.

• Associate Professor since 2016
• Experience across multiple oncology departments in Turkey
• Trained at Selcuk University Faculty of Medicine

Professor Cemil Bilir specializes in targeted therapies for lung cancer at VM Medical Park Pendik Hospital. His research includes advanced treatments at Northeastern University's Center for Pharmaceutical Biotechnology.

• Board-certified in medical oncology with 21 years of experience of experience
• Member of ASCO and ESMO – stays updated on global oncology standards
• Academic professor training future oncologists at Sakarya University
• Research background in pharmaceutical biotechnology enhances treatment options

Dr. Ozden specializes in medical oncology with a focus on lung cancer treatment at VM Medical Park Pendik Hospital.

• Completed medical oncology subspecialty at Kocaeli University
• Over 27 years of experience of experience in internal medicine and oncology
• Trained at Istanbul University's Cerrahpaşa Faculty of Medicine

Assoc. Prof. Nail Paksoy specializes in targeted therapies for lung cancer at Medipol Bahçelievler Hospital, with expertise in ALK-positive NSCLC treatments.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in international clinical trials for ALK-positive NSCLC
• Published research on real-world efficacy of ALK inhibitors
• Medical Oncology Fellowship at Istanbul University Oncology Institute

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı, specializing in targeted therapies for lung cancer.

• Member of American Society of Clinical Oncology (ASCO) since 2018
• Published multiple peer-reviewed articles on lung cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch
• Extensive experience in both clinical and academic oncology roles

Dr. Sridhar P.S. specializes in radiotherapy with a focus on lung cancer therapies, backed by over two decades of experience.

• Trained in radiotherapy at Banaras Hindu University
• Diplomate of National Board in radiotherapy
• Member of multiple oncology associations including the Society for Neuro-Oncology

Dr. Chaitainya Borde has performed over 30,000 PET scans and treated 1,000+ thyroid cancer patients at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Specializes in radioiodine and Lu-177 RN therapies
• Proficient in PET-CT scans and nuclear cardiology
• Published researcher in medical journals

Dr. Shruti Kate specializes in lung cancer treatment, with expertise in immunotherapy and metronomic therapy for advanced cancers. She presented her research at the World Conference on Lung Cancer.

• DM in Medical Oncology from Tata Memorial Hospital
• Member of ASCO, ESMO, and IASLC
• Experienced in treating solid tumors and hematological malignancies
• Works at HCG Manavata Cancer Centre